Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617
Conditions
- Prostate Cancer
- Prostate Cancer (Diagnosis)
- High-risk Prostate Cancer
- Localized Prostate Carcinoma
- Very High Risk Prostate Carcinoma
Interventions
- DRUG: 177 Lutetium Prostate-Specific Membrane Antigen 617
- DRUG: Actinium-225 Prostate-Specific Membrane Antigen 617
- PROCEDURE: Non-investigational, Prostatectomy
- PROCEDURE: Prostate Tissue Collection
- PROCEDURE: Single-photon emission computed tomography (SPECT)/Computerized tomography (CT)
- PROCEDURE: Blood Sample Collection
Sponsor
Thomas Hope
Collaborators